NPS Pharmaceuticals (NPSP) Timely Approval of Natpara Unlikely, Says Jefferies
Tweet Send to a Friend
Jefferies analyst Eun K. Yang weighed in on NPS Pharmaceuticals Inc. (NASDAQ: NPSP) after an FDA's panel voted 8-5 Friday ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
